You are here: Home » All Blog » PN » Polynucleotide vs Botulinum Toxin Type A: What’s the Difference?

Polynucleotide vs Botulinum Toxin Type A: What’s the Difference?

Author: Site Editor     Publish Time: 08-12-2026      Origin: Site

In facial rejuvenation, Polynucleotide vs Botulinum toxin type A has become a popular topic in aesthetic practice. Botulinum toxin type A is well known for treating dynamic wrinkles, while PN therapy is gaining attention for skin rejuvenation, particularly in delicate areas such as the periorbital area.

 

However, from our conversations with clinics and distributors, we have found that many frontline practitioners still have some confusion about these two treatments. Today, we will provide an in-depth analysis from three key perspectives: their mechanisms of action, indications, and strategies for combining them in aesthetic treatment plans.

What Are Polynucleotides? 

Polynucleotides (PN) are purified DNA fragments, commonly derived from fish sources such as salmon or trout. When injected into the skin, PN can support fibroblast activity and the skin’s natural regenerative processes. This may help support collagen production, improve skin elasticity, and enhance overall skin quality.

Polynucleotides (PN)

What Is Botulinum Toxin Type A?

Botulinum Toxin Type A (BoNT-A) is a neuromodulator that temporarily reduces muscle activity. It works by blocking the release of acetylcholine from nerve endings, preventing the targeted muscles from contracting as strongly. As a result, dynamic wrinkles such as frown lines, forehead lines, and crow’s feet can appear less noticeable.

Which Is Better for Different Concerns?

The choice depends on the type of concern being treated.

Botulinum toxin type A is mainly indicated for dynamic wrinkles—lines that appear or become more pronounced with facial movement. Common treatment areas include the glabella, forehead, and lateral canthal lines (crow’s feet).

When the main concern involves skin quality, such as fine lines, reduced elasticity, uneven texture, or thinning skin, polynucleotides (PN) may be more suitable. They may help improve the overall appearance of skin, making it look thicker, brighter, and firmer.

For example, if crow’s feet appear mainly when a patient smiles, BoNT-A may be an appropriate option. However, if visible lines remain when the face is at rest, this may indicate underlying changes in skin thickness and elasticity. In this case, PN may be considered as a treatment to help improve the appearance of these lines.

Why Does the Eye Area Require Special Attention?

The skin around the eyes is thin and delicate, and it is also constantly moving. As a result, signs of aging in this area often have a “combined” nature—including dynamic wrinkles, static fine lines, changes in skin quality, and pigmentation, which may occur at the same time.

For eye-area aging, the roles of the two treatments are actually quite clear:

Botulinum toxin addresses the “movement” problem. Crow’s feet at the outer corners of the eyes are one of the most classic applications of botulinum toxin in the eye area. By relaxing the overactive orbicularis oculi muscle, it can significantly reduce the fan-shaped lines that appear during facial expressions, with a clear and relatively fast effect.

PN, on the other hand, addresses the laxity associated with thinning skin, as well as dullness and reduced radiance around the eyes. Taking PNPure™ NeoEye Skin Booster as an example, after two to three treatments, patients have reported improvements in fine lines, skin tone evenness, and skin texture around the eyes. These effects can also be maintained for a period of time after reaching their peak.

For more detailed information on PN injection protocols and treatment feedback for the eye area, please refer to our previous dedicated article.

PNPure™ NeoEye Skin Booster

Can Polynucleotides and Botulinum Toxin Type A Be Used Together?

Yes. Botulinum toxin type A and polynucleotides together may be considered when a patient has both dynamic wrinkles and skin-quality concerns.

 

The reason is simple: aging is multifactorial. It involves both repeated muscle movement and changes in the skin itself.Botulinum toxin type A can reduce excessive muscle activity, while PN can be used to support skin quality.

 

Depending on the treatment goals, a practitioner may use the two treatments in the same overall treatment plan, either in different areas or at different stages. The appropriate sequence and timing should be determined based on the treatment area, patient anatomy, injection technique, product instructions, and practitioner experience.

 

FAQ

1、Can PN replace botulinum toxin type A?

No. PN does not produce the same muscle-relaxing effect as botulinum toxin and therefore cannot directly replace BoNT-A for dynamic wrinkles.

 

2、Is PN better than botulinum toxin type A for wrinkles?

Not necessarily. The choice depends on the type of wrinkle. Botulinum toxin type A is mainly used for dynamic wrinkles, while PN is more focused on skin quality.

 

3、Can botulinum toxin type A and PN be used together?

They may be combined when appropriate. The treatment plan should consider the treatment area, injection technique, product instructions, and individual patient factors.

 

Final Takeaway

The key difference in polynucleotide vs botulinum toxin type A is their treatment focus. Botulinum toxin type A reduces targeted muscle activity, while PN is used to support skin quality and repair.

For aesthetic clinics, the two do not need to be viewed as alternatives. When appropriate, they can serve different roles within a patient-specific facial rejuvenation plan.

CONTACT US

Leave a Message
Get an Instant Quote

Related Products

content is empty!

INFORMATION

Dermax Co., Ltd.
Block B, Wanda Bldg., No. 245 Jianhua South Street, Yuhua Dist., Shijiazhuang,Hebei, China
Tel: +86 16764319411
WhatsApp:+86 16764319411
Email: support@dermaxmed.com
 
facebook  insyoutube  
Copyright © 2020 Dermax Co., Ltd. All rights reserved.